UnitedHealth Group Incorporated (UNH) — closed signal from December 12, 2025
Partial Published before the outcome was known, scored automatically when the window closed on March 12, 2026.
Predicted vs. what happened
What happened
Reached 31% of the predicted growth at its peak, without hitting the target.
The thesis — published December 12, 2025
The analyst thinks UnitedHealth is a steadier pick than many others because recent price action and heavier-than-normal trading volume suggest big investors are positioning into year-end. That means UNH could keep rising even if the market shifts. The recommendation is to buy in the listed zone and only add more if broad markets dip and UNH holds up.
Primary drivers
- Price signals suggest the stock may keep moving in its current direction
- Unusually heavy options activity shows big investors are positioning
- Healthcare tends to hold up when growth stocks fall out of favor
- More consistent scoring makes this setup more reliable than hype-driven names
How it played out
UNH: target was not reached
Lyra published UNH at 344.16 on 2025-12-12, with an expected gain of 13% and a target of 388.90. The thesis pointed to recent price action, heavier-than-normal trading volume, unusual options activity, healthcare defensiveness, and steadier scoring than hype-driven names.
Inside the window, UNH rose at first but peaked at 357.87 on 2026-01-23, a 4% gain. It stayed below the target, so there were no days to target. By 2026-03-12, it ended at 277.05. The thesis only partially played out: early upside appeared, but the target was missed and the close was lower than publication.
Prices are shown split- and dividend-adjusted, matching what public charts show today.
Share this receipt
A scored call, published before the outcome was known. Paste the link anywhere — it unfurls as the card above.
Read the next call before it closes.
This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.